EP0804550A4

Ex vivo activation of immune cells

Abstract

This record has no abstract on file.

EP0804550A4, drawing sheet 1 — Sheet 1 of 9

Term

Term ended

Projected expiry passed 6 January 2015, 11.7 years ago.

9 sheets

Sheet 1
Sheet 2
Sheet 3
Sheet 4
Sheet 5
Sheet 6
Sheet 7
Sheet 8
Sheet 9

Every citation, both waysCites: the store holds 4 of 5

Citations
Document	Relation	Office	Category	Cited during	Relevant claims
WO9217567A1	Cites	World Intellectual Property Organization (WIPO)	A	Search report	1-60
WO9300918A1	Cites	World Intellectual Property Organization (WIPO)	A	Search report	1-60
WO9300918A	Cites	World Intellectual Property Organization (WIPO)	–	–	–
WO9217567A	Cites	World Intellectual Property Organization (WIPO)	–	–	–
ROSS S.D. ET AL.: "Autolymphocytes therapy (ALT) for disseminated melanoma: results in a pilot study of 26 patients", PROC ANN MEET AM SOC CLIN ONCOL, vol. 12, March 1993 (1993-03-01), pages a1326, XP002066052	Non-patent	–	–	Search report	–
GOLD J E ET AL: "Adoptively transferred ex vivo activated memory T cells with cyclophosphamide: Effective tumor-specific chemoimmunotherapy of advanced metastatic murine melanoma and carcinoma.", CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY 73 (1). 1994. 115-122, XP002066053	Non-patent	–	–	Search report	–
GOLD J E ET AL: "Autolymphocyte therapy: II. Dependence of in vivo anti-tumor specificity and long-term immunity against murine melanoma and carcinoma on ex vivo activated donor memory T-cells.", CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY 71 (3). 1994. 325-332, XP002066054	Non-patent	–	–	Search report	–
See also references of WO 9520649A1	Non-patent	–	–	Search report	–

11 members in 4 offices

This recordMember, by publication datePriority claim

Priority claims15

Priority claims
Document	Office	Kind	Date
18826294	United States of America	A	1994-01-27
18826294	United States of America	A	1994-01-27
19940188262	United States of America	–	1994-01-27
19940214400	United States of America	–	1994-03-16
21440094	United States of America	A	1994-03-16
21440094	United States of America	A	1994-03-16
19940300982	United States of America	–	1994-09-06
30098294	United States of America	A	1994-09-06
30098294	United States of America	A	1994-09-06
9500193	United States of America	W	1995-01-06
9500193	United States of America	W	1995-01-06
US19940188262	–	–	–
US19940214400	–	–	–
US19940300982	–	–	–
WO1995US00193	–	–	–

Members11

Family members, oldest first
Document	Office	Kind
US4716111A	United States of America	A	1987-12-29
US5192537A	United States of America	A	1993-03-09
WO9420120A1	World Intellectual Property Organization (WIPO)	A1	1994-09-15
WO9520649A1	World Intellectual Property Organization (WIPO)	A1	1995-08-03
AU1524095A	Australia	A	1995-08-15
EP0688223A1	European Patent Office (EPO)	A1	1995-12-27
US5569585A	United States of America	A	1996-10-29
EP0804550A1	European Patent Office (EPO)	A1	1997-11-05
EP0688223A4	European Patent Office (EPO)	A4	1998-05-13
US5766920A	United States of America	A	1998-06-16
EP0804550A4This record	European Patent Office (EPO)	A4	1998-08-05

7 legal events, as the office reported them to INPADOC

Over the term

Point at a mark for the event

Events

Legal events, newest first
	Event	Code
2000-02-02	Application deemed to be withdrawnWithdrawn18D	18D
1999-12-17	Information on the status of an ep patent application or granted ep patentGrantedSTATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWNSTAA	STAA
1998-08-05	Supplementary search report drawn up and despatchedA4	A4
1998-08-05	Designated contracting statesAK	AK
1997-11-05	Request for examination filed17P	17P
1997-11-05	Designated contracting statesAK	AK
1997-09-19	Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI	PUAI